Literature DB >> 21120686

Hepatitis B e-antigen persistency is associated with the properties of HBV-specific CD8 T cells in CHB patients.

Guoping Peng1, Benyan Luo, Jie Li, Dongjiu Zhao, Wei Wu, Feng Chen, Zhi Chen.   

Abstract

To investigate the correlation between the HBeAg and the properties of HBV-specific CD8 T cells, as well as liver injury, serum HBV markers, liver histology, the frequency and phenotypic characteristics of CD4(+)CD25(+) Treg and HBV-pentamer(+) CD8 T cells were measured. No significant differences between the median serum ALT levels, the frequency and Foxp3 expression of CD4(+)CD25(+) Treg, and liver fibrosis were observed. Higher HBV DNA levels in HBeAg(+) patients were observed, while liver necroinflammation was more severe in HBeAg(-) patients. Differences in HBV-pentamer(+) T cell frequency were not significant, but increased PD-1 and CTLA-4 expression on HBV-specific CD8 T cells was seen in the HBeAg(+) group. HBV-peptide stimulation with anti-PD-L1 and anti-CTLA-4 significantly increased the proliferation in PBMCs from both groups, but enhanced IFN-γ production only in the HBeAg(+) patients. Therefore, HBeAg persistency in CHB patients probably increased the expression of PD-1 and CTLA-4 on HBV-specific CD8 T cells, which may be associated with the low intensity of T cell responses and high HBV DNA load.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21120686     DOI: 10.1007/s10875-010-9483-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  35 in total

Review 1.  Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease.

Authors:  R P Perrillo
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

2.  Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.

Authors:  M K Maini; C Boni; G S Ogg; A S King; S Reignat; C K Lee; J R Larrubia; G J Webster; A J McMichael; C Ferrari; R Williams; D Vergani; A Bertoletti
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

3.  Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B.

Authors:  M Lindh; P Horal; A P Dhillon; G Norkrans
Journal:  J Viral Hepat       Date:  2000-07       Impact factor: 3.728

4.  HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection.

Authors:  I-Che Feng; Lok-Beng Koay; Ming-Jen Sheu; Hsing-Tao Kuo; Chi-Shu Sun; Chuan Lee; Wong-Lung Chuang; Shuen-Kuei Liao; Shih-Ling Wang; Ling-Yu Tang; Chia-Ju Cheng; Sun-Lung Tsai
Journal:  J Biomed Sci       Date:  2006-11-16       Impact factor: 8.410

5.  Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

Authors:  M-F Yuen; H-J Yuan; D K-H Wong; J C-H Yuen; W-M Wong; A O-O Chan; B C-Y Wong; K-C Lai; C-L Lai
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

6.  PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors.

Authors:  Michael A Curran; Welby Montalvo; Hideo Yagita; James P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

7.  CTLA4 silencing with siRNA promotes deviation of Th1/Th2 in chronic hepatitis B patients.

Authors:  Yongsheng Yu; Hao Wu; Zhenghao Tang; Guoqing Zang
Journal:  Cell Mol Immunol       Date:  2009-04       Impact factor: 11.530

8.  A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen.

Authors:  Margaret T Chen; Jean-Noel Billaud; Matti Sällberg; Luca G Guidotti; Francis V Chisari; Joyce Jones; Janice Hughes; David R Milich
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-05       Impact factor: 11.205

Review 9.  CTLA-4: new insights into its biological function and use in tumor immunotherapy.

Authors:  Jackson G Egen; Michael S Kuhns; James P Allison
Journal:  Nat Immunol       Date:  2002-07       Impact factor: 25.606

10.  PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.

Authors:  Guoping Peng; Shuping Li; Wei Wu; Xufei Tan; Yiqiong Chen; Zhi Chen
Journal:  Mol Immunol       Date:  2007-09-14       Impact factor: 4.407

View more
  13 in total

1.  Modulation of the function of dendritic cells in adolescents with chronic HBV infection by IFN-λ1.

Authors:  Haihua Sun; Lijuan Bi; Junying Zhou; Dongfang Zhou; Yinghui Liu; Guohua Jin; Wenzhao Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 2.  Immunopathogenesis of chronic hepatitis B.

Authors:  Irina P Balmasova; Nikolay D Yushchuk; Ospan A Mynbaev; Nageswara R Alla; Elena S Malova; Zhongjie Shi; Chang-Lu Gao
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 3.  T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection.

Authors:  Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

Review 4.  Hepatitis B virus e antigen and viral persistence.

Authors:  Kuen-Nan Tsai; Jing-Hsiung James Ou
Journal:  Curr Opin Virol       Date:  2021-10-28       Impact factor: 7.090

5.  Viral infection parameters not nucleoside analogue itself correlates with host immunity in nucleoside analogue therapy for chronic hepatitis B.

Authors:  Cheng-Zhong Li; Jing-Jing Hu; Jian-Ya Xue; Wei Yin; Ya-Yun Liu; Wen-Han Fan; Hao Xu; Xue-Song Liang
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

6.  The expression of programmed death-1 in circulating CD4+ and CD8+ T cells during hepatitis B virus infection progression and its correlation with clinical baseline characteristics.

Authors:  Ping Xu; Yong-Jing Chen; Hui Chen; Xiao-Yan Zhu; Hua-Feng Song; Li-Juan Cao; Xue-Feng Wang
Journal:  Gut Liver       Date:  2013-12-24       Impact factor: 4.519

Review 7.  The sterile inflammation in the exacerbation of HBV-associated liver injury.

Authors:  Qiao Yang; Yu Shi; Ying Yang; Guohua Lou; Zhi Chen
Journal:  Mediators Inflamm       Date:  2015-03-29       Impact factor: 4.711

8.  Plasmacytoid Dendritic Cell Function and Cytokine Network Profiles in Patients with Acute or Chronic Hepatitis B Virus Infection.

Authors:  Ming-Hui Li; Lu Zhang; Dan Zhang; Wei-Hua Cao; Tian-Lin Qi; Hong-Xiao Hao; Xing-Yue Wang; Chong-Ping Ran; Xiao-Jing Qu; Shun-Ai Liu; Yao Lu; Ge Shen; Shu-Ling Wu; Min Chang; Ru-Yu Liu; Lei-Ping Hu; Wen-Hao Hua; Gang Wan; Jun Cheng; Yao Xie
Journal:  Chin Med J (Engl)       Date:  2018-01-05       Impact factor: 2.628

9.  The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer.

Authors:  Xiao-li Wei; Miao-zhen Qiu; Wei-wei Chen; Ying Jin; Chao Ren; Feng Wang; Hui-yan Luo; Zhi-qiang Wang; Dong-sheng Zhang; Feng-hua Wang; Yu-hong Li; Rui-hua Xu
Journal:  J Transl Med       Date:  2013-10-08       Impact factor: 5.531

10.  Infected hematopoietic stem cells and with integrated HBV DNA generate defective T cells in chronic HBV infection patients.

Authors:  Y Shi; Y Lan; F Cao; Y Teng; L Li; F Wang; J Li; J Zhou; Y Li
Journal:  J Viral Hepat       Date:  2014-03-12       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.